Peripheral artery disease measuring for patient ankle-brachial index (ABI) test limb ischemia When we think of clogged arteries, most of us think about the heart. “But buildup of fatty plaques can ...

Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that its abstract titled, "Discovery of VS-214, a ...

Dr. Dua, a vascular surgeon, is co-director of the Peripheral Artery Disease Center and Limb Evaluation and Preservation Program at Massachusetts General Hospital. See more of our coverage in your ...

In patients with peripheral artery disease undergoing revascularization, major adverse limb events were more common with ...

A new study by Intermountain Health researchers finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and ...

PHOENIX — A Surprise man who nearly lost his foot to a cardiovascular condition is sounding the alarm about peripheral arterial disease. This condition occurs when plaque builds up in a person’s blood ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE trial, ...

HAPPENING TODAY, THERE IS AN EVENT AIMED AT RAISING AWARENESS ABOUT BLACK MEN’S HEALTH, SPECIFICALLY THE IMPACTS OF PERIPHERAL ARTERY DISEASE. IT’S A DISEASE AFFECTING MILLIONS OF AMERICANS EACH YEAR.

Type 2 diabetes can turn immune cells that help with tissue repair and anti-inflammatory responses into triggers of chronic ...

Imagine putting your socks on one morning and noticing your big toe, which has been painful for a few weeks, has started turning black. A trip to your doctor ends in being referred urgently to a ...

BD is putting a fresh spin on an old awareness drive, returning to the 12-year-old “Love Your Limbs” campaign to mark Peripheral Artery Disease (PAD) Awareness Month. The company, which sells PAD ...

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.